Epidemiologic approach of doping in sport. A review, J Sports Med Phys Fitness, vol.37, issue.3, pp.218-242, 1997. ,
Doping in fitness sports: estimated number of unreported cases and individual probability of doping, Addiction, vol.101, issue.11, pp.1640-1644, 2006. ,
Recreational athletes and doping, a survey in 11 gyms in the area of Frankfurt/Main, MMW Fortschr Med, vol.155, issue.2, pp.41-44, 2013. ,
The prevalence and characteristics of performance-enhancing drug use among bodybuilding athletes in the south of Iran, Bushehr. Asian J Sports Med, vol.7, issue.3, 2016. ,
The misuse of anabolic-androgenic steroids among Iranian recreational male body-builders and their related psycho-socio-demographic factors, Iran J Public Health, vol.44, issue.12, pp.1662-1671, 2015. ,
The use of nutritional supplements among recreational athletes in Athens, Greece, Int J Sport Nutr Exerc Metab, vol.21, issue.5, pp.377-84, 2011. ,
Anabolic ergogenic substance users in fitness-sports: A distinct group supported by the health care system, Drug Alcohol Depend, vol.81, issue.1, pp.11-20, 2006. ,
Anabolicandrogenic steroid use among Brazilian bodybuilders, Subst Use Misuse, vol.49, issue.9, pp.1138-1183, 2014. ,
Prevalence of anabolic steroid use and associated factors among body-builders in Hamadan, western province of Iran, J Res Health Sci, vol.14, issue.2, pp.163-169, 2014. ,
Use of anabolicandrogenic steroids among body builders-frequency and attitudes, J Intern Med, vol.227, issue.6, pp.407-418, 1990. ,
Supplement consumption in body builder athletes, J Res Med Sci Off J Isfahan Univ Med Sci, vol.16, issue.10, pp.1347-53, 2011. ,
Frequency of anabolic steroids abuse in bodybuilder athletes in Kerman city, Addict Health, vol.1, issue.1, pp.25-34, 2009. ,
Liste des Interdictions, vol.9, 2016. ,
Performance-enhancing substances in sports: a review of the literature, Sports Med Auckl NZ, vol.45, issue.4, pp.517-548, 2015. ,
Adverse health consequences of performance-enhancing drugs: an endocrine society scientific statement, Endocr Rev, vol.35, issue.3, pp.341-75, 2014. ,
DOI : 10.1210/er.2013-1058
URL : https://academic.oup.com/edrv/article-pdf/35/3/341/8863240/edrv0341.pdf
The state of dietary supplement adverse event reporting in the United States, Pharmacoepidemiol Drug Saf, vol.17, issue.10, pp.962-70, 2008. ,
Avis de l'Agence nationale de sécurité sanitaire de l'alimentation, de l'environnement et du travail relatif aux risques liés à la consommation de compléments alimentaires destinés aux sportifs visant le développement musculaire ou la diminution de la masse grasse ,
, , 2016.
, Code du sport-Article L232-3
,
Doping in sport: doctors are providing drugs, Br J Sports Med, vol.31, issue.3, pp.258-267, 1997. ,
DOI : 10.1136/bjsm.31.3.258-b
URL : https://bjsm.bmj.com/content/31/3/258.3.full.pdf
Doping in sport: a review of medical practitioners' knowledge, attitudes and beliefs, Int J Drug Policy, vol.22, issue.3, pp.198-202, 2011. ,
Evaluation of prevalence of « doping » among Italian athletes, Lancet, vol.336, issue.8722, pp.1048-50, 1990. ,
General practitioner knowledge of prohibited substances in sport, Br J Sports Med, vol.31, issue.2, pp.129-160, 1997. ,
General practitioners and doping in sport: attitudes and experience, Br J Sports Med, vol.37, issue.4, pp.335-343, 2003. ,
DOI : 10.1136/bjsm.37.4.335
URL : https://bjsm.bmj.com/content/37/4/335.full.pdf
General practitioners knowledge, practice and training requirements in relation to doping in sport, Ir Med J, vol.102, issue.1, pp.8-10, 2009. ,
Can we measure accurately the prevalence of doping?, J Med Sci Sports, vol.21, issue.6, pp.132-174, 2011. ,
, État des lieux et nouvelles perspectives, vol.1
,
Doping: epidemiological studies. Presse Médicale Paris Fr, vol.29, pp.1365-72, 1983. ,
Vitamin/mineral supplement use among athletes: a review of the literature, Int J Sport Nutr, vol.4, issue.4, pp.320-354, 1994. ,
Anabolic steroid users' attitudes towards physicians, Addict Abingdon Engl, vol.99, issue.9, pp.1189-94, 2004. ,
Performance-enhancing drugs on the web: a growing public-health issue, Am J Addict, vol.22, issue.2, pp.158-61, 2013. ,
Epidemiology of doping in rural gyms in the district of Traunstein, MMW Fortschr Med, vol.157, issue.5, pp.5-8, 2015. ,
Intake of nutritional supplements among people exercising in gyms and influencing factors, Nutr Burbank Los Angel Cty Calif, vol.26, issue.6, pp.604-615, 2010. ,
Le culte de la performance, Calmann-Levy ,
URL : https://hal.archives-ouvertes.fr/halshs-00585599
Les règles de la méthodologie sociologique ,
Histoire du dopage et des conduites dopantes: Les alchimistes de la performance ,
,
Disponible sur, 2016. ,
The history of Ephedra (ma-huang), J R Coll Physicians Edinb, vol.41, pp.78-84, 2011. ,
, Actual Pharm, vol.485, pp.45-53, 2009.
Coca et cocaïne : De l'usage traditionnel à l'addiction, 2012. ,
Légendes d, Olympie. Rev Olymp, pp.66-67, 1973. ,
Dict Biogr Frères Prêch Dominic Prov Fr XIXe-XXe Siècles, 2015. ,
Crooked: A History of Cheating in Sports, 2009. ,
Les forçats de la route, Arléa ,
Dopage: L'imposture des performances, Mensonges et vérités sur l'histoire de la triche ,
UCI a couvert Lance Armstrong dès le Tour 1999. lemonde.fr ,
, Discovery Channel. Lance Armstrong on Oprah Part, 2013.
WADA Investigation of Sochi Allegations, p.97, 2016. ,
Dopage et société. Ellipses. Paris, vol.447, 2000. ,
Tendant à la répression des stimulants à l'occasion des compétitions sportives, 1965. ,
, Décret n°66-373 du 10 juin 1966 portant règlement d'administration publique pour l'application de la loi N°65-412 du 1er juin 1965 tendant à la répression de l'usage des stimulants à l'occasion des compétitions sportives
Le dopage des intellectuels et des sportifs, Prod Prob Pharm, issue.22, pp.5-15, 1967. ,
juin 1989 relative à la répression du dopage des animaux participant à des manifestations et compétitions sportives ,
, , 2016.
Liste des Interdictions, p.9, 2016. ,
du 23 mars 1999 relative à la protection de la santé des sportifs et à la lutte contre le dopage, pp.99-223 ,
, 405 du 5 avril 2006 relative à la lutte contre le dopage et à la protection de la santé des sportifs, vol.6, p.5193, 2006.
Effectuer une demande d'AUT ,
,
, Décret n° 2016-1157 du 24 août 2016 relatif au certificat médical attestant de l'absence de contre-indication à la pratique du sport
,
, Avis relatif à la sécurité des salles de remise en forme
,
,
Can we measure accurately the prevalence of doping?, J Med Sci Sports, vol.21, issue.6, pp.132-174, 2011. ,
,
Epidemiologic approach of doping in sport. A review, J Sports Med Phys Fitness, vol.37, issue.3, pp.218-242, 1997. ,
Doping: epidemiological studies. Presse Médicale Paris Fr, vol.29, pp.1365-72, 1983. ,
Epidemiology of doping in rural gyms in the district of Traunstein, MMW Fortschr Med, vol.157, issue.5, pp.5-8, 2015. ,
Doping in fitness sports: estimated number of unreported cases and individual probability of doping, Addiction, vol.101, issue.11, pp.1640-1644, 2006. ,
Recreational athletes and doping, a survey in 11 gyms in the area of Frankfurt/Main, MMW Fortschr Med, vol.155, issue.2, pp.41-44, 2013. ,
The prevalence and characteristics of performance-enhancing drug use among bodybuilding athletes in the south of Iran, Bushehr. Asian J Sports Med, vol.7, issue.3, 2016. ,
The misuse of anabolic-androgenic steroids among Iranian recreational male body-builders and their related psycho-socio-demographic factors, Iran J Public Health, vol.44, issue.12, pp.1662-1671, 2015. ,
The use of nutritional supplements among recreational athletes in Athens, Greece, Int J Sport Nutr Exerc Metab, vol.21, issue.5, pp.377-84, 2011. ,
Anabolic ergogenic substance users in fitness-sports: A distinct group supported by the health care system, Drug Alcohol Depend, vol.81, issue.1, pp.11-20, 2006. ,
Anabolicandrogenic steroid use among Brazilian bodybuilders, Subst Use Misuse, vol.49, issue.9, pp.1138-1183, 2014. ,
Prevalence of anabolic steroid use and associated factors among body-builders in Hamadan, western province of Iran, J Res Health Sci, vol.14, issue.2, pp.163-169, 2014. ,
Use of anabolicandrogenic steroids among body builders-frequency and attitudes, J Intern Med, vol.227, issue.6, pp.407-418, 1990. ,
Supplement consumption in body builder athletes, J Res Med Sci Off J Isfahan Univ Med Sci, vol.16, issue.10, pp.1347-53, 2011. ,
Automédication chez les coureurs de trail et d'ultra-trail: Enquête lors de l'infernal Trail des Vosges, 2014. ,
Drugs, recreational drug use and attitudes towards doping of high school athletes, Int J Sports Med, vol.25, issue.2, pp.133-141, 2004. ,
Vitamin/mineral supplement use among athletes: a review of the literature, Int J Sport Nutr, vol.4, issue.4, pp.320-354, 1994. ,
Creatine supplementation in Wisconsin high school athletes, WMJ Off Publ State Med Soc Wis, vol.101, issue.2, pp.25-30, 2002. ,
Frequency of anabolic steroids abuse in bodybuilder athletes in Kerman city, Addict Health, vol.1, issue.1, pp.25-34, 2009. ,
knowledge and attitude of prohibited substances use (doping) among Saudi sport players, Subst Abuse Treat Prev Policy, vol.11, p.14, 2016. ,
Intake of nutritional supplements among people exercising in gyms and influencing factors, Nutr Burbank Los Angel Cty Calif, vol.26, issue.6, pp.604-615, 2010. ,
, Fédération nationale des observatoires régionaux de santé. Étude qualitative sur les représentations concernant le dopage et sa prévention chez les sportifs et leur entourage
, Disponible sur, p.374, 2014.
Anabolic steroid users' attitudes towards physicians, Addict Abingdon Engl, vol.99, issue.9, pp.1189-94, 2004. ,
Doping in sport: a review of medical practitioners' knowledge, attitudes and beliefs, Int J Drug Policy, vol.22, issue.3, pp.198-202, 2011. ,
General practitioners and doping in sport: attitudes and experience, Br J Sports Med, vol.37, issue.4, pp.335-343, 2003. ,
General practitioners knowledge, practice and training requirements in relation to doping in sport, Ir Med J, vol.102, issue.1, pp.8-10, 2009. ,
Knowledge on and attitudes of doping in sport, of young trainees in internal and general-familial medicine, Pharmacologyonline, vol.2, pp.1-5, 2006. ,
Évaluation des connaissances du médecin généraliste sur le dopage, p.87, 2008. ,
,
Performance-enhancing substances in sports: a review of the literature, Sports Med Auckl NZ, vol.45, issue.4, pp.517-548, 2015. ,
Adverse health consequences of performance-enhancing drugs: an endocrine society scientific statement, Endocr Rev, vol.35, issue.3, pp.341-75, 2014. ,
The state of dietary supplement adverse event reporting in the United States, Pharmacoepidemiol Drug Saf, vol.17, issue.10, pp.962-70, 2008. ,
Adverse event monitoring and multivitamin-multimineral dietary supplements, Am J Clin Nutr, vol.85, issue.1, pp.323-327, 2007. ,
Avis de l'Agence nationale de sécurité sanitaire de l'alimentation, de l'environnement et du travail relatif aux risques liés à la consommation de compléments alimentaires destinés aux sportifs visant le développement musculaire ou la diminution de la masse grasse ,
, , 2016.
Effect of high protein vs high carbohydrate intake on insulin sensitivity, body weight, hemoglobin A1c, and blood pressure in patients with type 2 diabetes mellitus, J Am Diet Assoc, vol.105, issue.4, pp.573-80, 2005. ,
Comparative effects of low-carbohydrate high-protein versus low-fat diets on the kidney, Clin J Am Soc Nephrol, vol.7, issue.7, pp.1103-1114, 2012. ,
The impact of protein intake on renal function decline in women with normal renal function or mild renal insufficiency, Ann Intern Med, vol.138, issue.6, pp.460-467, 2003. ,
The absorption of orally supplied beta-alanine and its effect on muscle carnosine synthesis in human vastus lateralis, Amino Acids, vol.30, issue.3, pp.279-89, 2006. ,
Larginine therapy in acute myocardial infarction: the Vascular Interaction With Age in Myocardial Infarction (VINTAGE MI) randomized clinical trial, JAMA, vol.295, issue.1, pp.58-64, 2006. ,
, glycérol et l'administration intraveineuse d'albumine, dextran, hydroxyéthylamidon et mannitol.-Acétazolamide ; amiloride ; bumétanide ; canrénone ; chlortalidone ; acide étacrynique ; furosémide ; indapamide ; métolazone ; spironolactone ; thiazides, par ex. bendrofluméthiazide, chlorothiazide, et hydrochlorothiazide ; triamtérène et vaptans, par ex. tolvaptan. Sauf :-la drospirénone
, de n'importe quelle quantité des substances qui suivent étant soumises à un niveau seuil : formotérol, salbutamol, cathine, éphédrine, méthyléphédrine et pseudoéphédrine, conjointement avec un diurétique ou un agent masquant, sera consideré comment un résultat d'analyse anormal (RAA) sauf si le sportif a une autorisation d'usage à des fins thérapeutiques (AUT) approuvée pour cette substance